Myomo Inc (MYO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Myomo Inc (MYO) has a cash flow conversion efficiency ratio of -0.244x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.20 Million) by net assets ($9.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Myomo Inc - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Myomo Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Myomo Inc for a breakdown of total debt and financial obligations.
Myomo Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Myomo Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GeneReach Biotechnology
TWO:4171
|
0.020x |
|
Viomi Technology ADR
NASDAQ:VIOT
|
-0.320x |
|
Quonia SOCIMI SA
MC:YQUO
|
0.013x |
|
RedCloud Holdings plc Ordinary Shares
NASDAQ:RCT
|
1.989x |
|
Samhwa Crown
KO:004450
|
0.022x |
|
Good Way Technology Co Ltd
TWO:3272
|
0.056x |
|
Toplus Global Co Ltd
TWO:3522
|
-0.039x |
|
Dongil Metal Co. Ltd
KQ:109860
|
0.002x |
Annual Cash Flow Conversion Efficiency for Myomo Inc (2014–2025)
The table below shows the annual cash flow conversion efficiency of Myomo Inc from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see MYO market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $11.40 Million | $-14.51 Million | -1.273x | -855.95% |
| 2024-12-31 | $24.71 Million | $-3.29 Million | -0.133x | +80.61% |
| 2023-12-31 | $8.99 Million | $-6.17 Million | -0.687x | +57.33% |
| 2022-12-31 | $6.36 Million | $-10.23 Million | -1.609x | -159.71% |
| 2021-12-31 | $15.41 Million | $-9.55 Million | -0.620x | +20.67% |
| 2020-12-31 | $11.57 Million | $-9.03 Million | -0.781x | +86.22% |
| 2019-12-31 | $1.82 Million | $-10.34 Million | -5.668x | -279.12% |
| 2018-12-31 | $6.43 Million | $-9.61 Million | -1.495x | -202.36% |
| 2017-12-31 | $12.45 Million | $-6.15 Million | -0.494x | -370.63% |
| 2016-12-31 | $-17.53 Million | $-3.20 Million | 0.183x | -92.67% |
| 2015-12-31 | $-1.34 Million | $-3.33 Million | 2.492x | +169.67% |
| 2014-12-31 | $712.11K | $-2.55 Million | -3.577x | -- |
About Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more